Dac Biotech

Executive Summary

Dac Biotech, established in 2003 and headquartered in Zhuhai, China, is a commercial-stage diagnostics company focused on developing innovative tools for disease detection and health monitoring. The company leverages its proprietary technologies to enhance diagnostic accuracy and efficiency in clinical and laboratory settings. With an employee base of 50–200, Dac Biotech has established itself in the Chinese diagnostics market, though its financial details remain undisclosed as a private entity. The company's product portfolio likely includes reagents, instruments, or point-of-care tests targeting infectious diseases, cancers, or chronic conditions. Dac Biotech's competitive edge lies in its cost-effective solutions tailored to local healthcare needs, positioning it for growth amid China's expanding diagnostic spending driven by aging population and policy support.

Upcoming Catalysts (preview)

• Q3 2026Launch of a New Diagnostic Test for Infectious Diseases60% success
• TBDPartnership with a Major Hospital Group or Distributor40% success